A Prospective Study of Adverse Drug Reactions in Hospitalized Children

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1999 Jun 26

PMID 10383547

Citations 29

Authors

I Martinez-Mir

M Garcia-Lopez

V Palop

J M Ferrer

E Rubio

F J Morales-Olivas

Affiliations

Soon will be listed here.

Abstract

Aims: There are few publications of adverse drug reactions (ADRs) among paediatric patients, though ADR incidence is usually stated to be higher during the first year of life and in male patients. We have carried out a prospective study to assess the extent, pattern and profile risk for ADRs in hospitalized patients between 1 and 24 months of age.

Methods: An intensive events monitoring scheme was used. A total of 512 successive admissions to two medical paediatric wards (47 beds) were analysed. The hospital records were screened daily during two periods (summer, 105 days and winter, 99 days), and adverse clinical events observed were recorded.

Results: A total of 282 events were detected; of these, 112 were considered to be manifestations of ADRs. The cumulative incidence was 16.6%, no differences being observed between periods. Although there were no differences between patients under and over 12 months of age, risk was found to be significantly higher among girls compared with boys (RR=1.66, 95% CI 1.03-2.52). The gastro-intestinal system was most frequently affected. The therapeutic group most commonly implicated was anti-infective drugs and vaccines (41.5%). The ADRs were mild or moderate in over 90% of cases. A consistent relationship was noted between the number of drugs administered and the incidence of ADRs.

Conclusions: Hospitalized patients exhibited an ADR risk profile that included female sex and the number of drugs administered. No particular age predisposition was observed. The most commonly prescribed drugs are those most often implicated in ADRs in paediatric patients.

Citing Articles

Research on prescribing cascades: a scoping review.

Chen Z, Liu Z, Zeng L, Huang L, Zhang L Front Pharmacol. 2023; 14:1147921.

PMID: 37465527 PMC: 10350531. DOI: 10.3389/fphar.2023.1147921.

Knowledge and Barriers Among Physicians Toward Adverse Drug Reaction Reporting at a Tertiary Care Hospital in Saudi Arabia.

Al-Abdulkarim D, Aljadhey H, Mahmoud M, Poff G, Hassali M, Ali S Hosp Pharm. 2021; 56(4):368-373.

PMID: 34381276 PMC: 8326870. DOI: 10.1177/0018578720910385.

Adverse Drug Reactions in Children: Pediatric Pharmacy and Drug Safety.

Rieder M J Pediatr Pharmacol Ther. 2019; 24(1):4-9.

PMID: 30837807 PMC: 6397008. DOI: 10.5863/1551-6776-24.1.4.

Adverse drug reactions in hospitalized Colombian children.

De Las Salas R, Diaz-Agudelo D, Burgos-Florez F, Vaca C, Serrano-Merino D Colomb Med (Cali). 2016; 47(3):142-147.

PMID: 27821893 PMC: 5091272.

Spontaneous adverse drug reaction reports for neonates and infants in the UK 2001-2010: content and utility analysis.

Hawcutt D, Russell N, Maqsood H, Kouranloo K, Gomberg S, Waitt C Br J Clin Pharmacol. 2016; 82(6):1601-1612.

PMID: 27597136 PMC: 5099553. DOI: 10.1111/bcp.13067.

References

Classen D, Pestotnik S, Evans R, Burke J . Computerized surveillance of adverse drug events in hospital patients. JAMA. 1991; 266(20):2847-51. View

Leary P . Adverse reactions in children. Special considerations in prevention and management. Drug Saf. 1991; 6(3):171-82. DOI: 10.2165/00002018-199106030-00003. View

Meyboom R . Adverse reaction to drugs in children, experiences with "spontaneous monitoring" in The Netherlands. Bratisl Lek Listy. 1991; 92(11):554-9. View

Lee D, Balasubramaniam K, Ali H . Drug utilization studies: their transferability between industrialized and developing countries. WHO Reg Publ Eur Ser. 1993; 45:193-218. View

Morales-Olivas F, Ferrer J, Palop V, Rubio E . [Adverse reactions from angiotensin-converting enzyme inhibitor drugs reported by the yellow card]. Med Clin (Barc). 1994; 103(9):321-5. View

Martinez-Mir I, Garcia-Lopez M, Palop V, Ferrer J, Estan L, Rubio E . A prospective study of adverse drug reactions as a cause of admission to a paediatric hospital. Br J Clin Pharmacol. 1996; 42(3):319-24. PMC: 2042676. DOI: 10.1046/j.1365-2125.1996.04076.x. View

Bates D, Spell N, Cullen D, Burdick E, Laird N, Petersen L . The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997; 277(4):307-11. View

Mitchell A, Goldman P, Shapiro S, Slone D . Drug utilization and reported adverse reactions in hospitalized children. Am J Epidemiol. 1979; 110(2):196-204. DOI: 10.1093/oxfordjournals.aje.a112804. View

Moreland T, Rylance G, Christopher L, Stevenson I . Patterns of drug prescribing for children in hospital. Eur J Clin Pharmacol. 1978; 14(1):39-46. DOI: 10.1007/BF00560256. View

10.

Arnau J, Camps A, Curull V, Muniz R, Laporte J . [A program for the detection of adverse reactions to drugs in hospitalized patients. Methods and results of the pilot phase]. Med Clin (Barc). 1984; 82(10):433-7. View

11.

Kramer M, Hutchinson T, Flegel K, Naimark L, Contardi R, Leduc D . Adverse drug reactions in general pediatric outpatients. J Pediatr. 1985; 106(2):305-10. DOI: 10.1016/s0022-3476(85)80314-0. View

12.

Diez Jarilla J, Munoz Bellido J, DE CASTRO DEL POZO S . [Iatrogenic pathology in an internal medicine department. II. Adverse reactions to drugs]. Med Clin (Barc). 1986; 87(4):131-4. View

13.

Woods C, Rylance M, Cullen R, Rylance G . Adverse reactions to drugs in children. Br Med J (Clin Res Ed). 1987; 294(6576):869-70. PMC: 1245929. DOI: 10.1136/bmj.294.6576.869-a. View

14.

Sanz E, Boada J . Adverse drug reactions in paediatric outpatients. Int J Clin Pharmacol Res. 1987; 7(2):169-72. View

15.

Hurwitz N . Predisposing factors in adverse reactions to drugs. Br Med J. 1969; 1(5643):536-9. PMC: 1982240. DOI: 10.1136/bmj.1.5643.536. View

16.

. Drug surveillance. Problems and challenges. Pediatr Clin North Am. 1972; 19(1):117-29. DOI: 10.1016/s0031-3955(16)32670-0. View

17.

Mckenzie M, Stewart R, WEISS C, Cluff L . A pharmacist-based study of the epidemiology of adverse drug reactions in pediatric medicine patients. Am J Hosp Pharm. 1973; 30(10):898-903. View

18.

Whyte J, Greenan E . Drug usage and adverse drug reactions in paediatric patients. Acta Paediatr Scand. 1977; 66(6):767-75. DOI: 10.1111/j.1651-2227.1977.tb07987.x. View

19.

Skegg D, DOLL R . The case for recording events in clinical trials. Br Med J. 1977; 2(6101):1523-4. PMC: 1632767. DOI: 10.1136/bmj.2.6101.1523. View

20.

Mitchell A, Lacouture P, SHEEHAN J, Kauffman R, Shapiro S . Adverse drug reactions in children leading to hospital admission. Pediatrics. 1988; 82(1):24-9. View